Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Crystal Cunanan is active.

Publication


Featured researches published by Crystal Cunanan.


The Annals of Thoracic Surgery | 2001

Tissue characterization and calcification potential of commercial bioprosthetic heart valves.

Crystal Cunanan; Christine May Cabiling; Tan T Dinh; ShihHwa Shen; Phihoa Tran-Hata; James H Rutledge; Michael C. Fishbein

BACKGROUND Tissue properties may contribute to intrinsic calcification of bioprosthetic heart valves. Phospholipids have been proposed as potential nucleation sites for calcification. Other tissue properties might also be important in calcification. METHODS Commercial and control bioprosthetic valve tissues were characterized by shrinkage temperature, moisture content, free amine content, phospholipid content, and calcification level after 90-day rat subcutaneous implantation as described. RESULTS Shrinkage temperature, moisture content, and free amine content were typical for glutaraldehyde-cross-linked tissues. Phospholipid and calcium levels varied considerably among valve types. There was a significant correlation between phospholipid levels and calcification (r = 0.63, p = 0.04). Sulzer Carbomedics Mitroflow and Toronto SPV valve tissues had significantly more calcification than other commercial bioprostheses in this study (p < 0.01). Carpentier-Edwards Duraflex, CE SAV, and CE PERIMOUNT valve tissues had significantly less calcification than Medtronic Mosaic in this animal model (p < 0.02). CONCLUSIONS Processes that reduce phospholipid levels are associated with reduced calcification in the rat subcutaneous model. Significant differences in calcification level were found among commercially available valves. The clinical significance of these results is unknown.


The Annals of Thoracic Surgery | 2008

Trilogy Pericardial Valve : Hemodynamic Performance and Calcification in Adolescent Sheep

Willem Flameng; Bart Meuris; Geofrey De Visscher; Crystal Cunanan; Ernie Lane; Erik Verbeken; Paul Herijgers; Marie-Christine Herregods

BACKGROUND We assessed the hemodynamic performance and calcification potential of a new design of bovine pericardial valve, the Trilogy valve (Arbor Surgical Technologies Inc, Irvine, CA). We compared this new valve with the Perimount valve (Edwards Lifesciences, Irvine, CA) in a randomized prospective study in adolescent sheep. METHODS Nine Trilogy valves (size 21) and six Perimount valves (size 23 or 25) were implanted in the mitral position in adolescent sheep and studied during five months. Hemodynamic measurements were performed at one week, three months, and five months using transthoracic echocardiography. Valve calcification was assessed by X-ray and calcium content was measured by atomic absorption spectrometry after five months implantation in sheep. Tissues were also evaluated histologically (Von Kossa staining). RESULTS The nine Trilogy valves had lower peak velocity, peak gradient, and mean gradient compared with the six Perimount valves. These 21-mm Trilogy valves had similar deceleration time and effective orifice area compared with the 23- and 25-mm Perimount valves. Calcification of the Trilogy valves was significantly lower than Perimount valves (p < 0.01), particularly in the commissural (p < 0.01) and free margin regions (p < 0.03). In all parameters assessed, the Trilogy valves exhibited less variation valve-to-valve compared with Perimount valves. CONCLUSIONS These findings demonstrate that a valve designed to reduce stress in the tissue, improve leaflet kinematics, with advanced antimineralization treatment, can exhibit superior calcification resistance in the mitral position of adolescent sheep. The trilobal geometry and independent leaflet suspension design, combined with an advanced tissue treatment, appears to be a promising breakthrough in the effort to develop a more durable and hemodynamically efficient bioprosthetic valve.


The Annals of Thoracic Surgery | 2001

Biochemical properties of heat-treated valvular bioprostheses

Sophie Carpentier; Ming Shen; Lin Chen; Crystal Cunanan; Bernard Martinet; Alain Carpentier

BACKGROUND Preliminary studies showed that heat treatment of glutaraldehyde preserved valvular bioprostheses mitigates calcification. This study was carried out to define the physicochemical characteristics of the heat-treated tissues to elucidate the mechanism involved in the mitigation. METHODS Glut bovine pericardium or porcine valve samples were treated at 50 degrees C in a 0.625% glutaraldehyde solution for 2 months. Some samples underwent assay for shrinkage temperature, moisture content, ninhydrin test, and acid hydrolysis, and other samples were incubated in human serum for 3 days and then analyzed by electrophoresis to study protein adsorption. RESULTS Heat treatment mitigated calcification without adversely affecting shrinkage temperature (84.81 degrees C versus 83.95 degrees C) and moisture content (78.68% versus 78.71%). A significant reduction in free amino groups (0.15 versus 0.37 mol NH2/mol collagen) and a significant increase in resistance to acid hydrolysis were observed. Total protein content was similar, but significant differences were found for four proteins adsorbed in the tissues (167, 45, 11.6, and 10 kDa). CONCLUSIONS The anticalcification effect of heat treatment may be attributed to structural changes, lipid extraction, increased resistance, and modifications of the type and concentration of the proteins adsorbed in the tissue.


Archive | 2001

Expandable annuloplasty ring

Alexandre Carpentier; Alain F. Carpentier; Hung Lam; Thanh Van Nguyen; Van Le Huynh; Crystal Cunanan


Archive | 2004

Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia

Michael N. Helmus; Crystal Cunanan; Patrice Tremble


Archive | 2001

Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby

Alain F. Carpentier; Sophie Carpentier; Crystal Cunanan; Lillian Quintero; Michael N. Helmus; Christine Loshbaugh; H. Chris Sarner


Archive | 2003

Method for treatment of biological tissues to mitigate post-implantation calcification and thrombosis

Alain Carpentier; Sophie Carpentier; Crystal Cunanan; Lillian J. Quintero; Michael N. Helmus; Christine Loshbaugh; H. Chris Sarner


Archive | 2007

Treating biological tissues to mitigate post-implantation calcification

Alain F. Carpentier; Sophie Carpentier; Crystal Cunanan; Lillian Quintero; Michael N. Helmus; Christine Loshbaugh; H. Chris Sarner


Archive | 2001

Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia

Michael N. Helmus; Crystal Cunanan; Patrice Tremble


Archive | 2000

Methods for quantitative and qualitative analyses of phospholipids using one-dimensional thin layer chromatography

Tan Thanh Dinh; Patrice Tremble; Crystal Cunanan; Christine May Cabiling

Collaboration


Dive into the Crystal Cunanan's collaboration.

Top Co-Authors

Avatar

Michael N. Helmus

Edwards Lifesciences Corporation

View shared research outputs
Top Co-Authors

Avatar

Patrice Tremble

Edwards Lifesciences Corporation

View shared research outputs
Top Co-Authors

Avatar

Christine Loshbaugh

Edwards Lifesciences Corporation

View shared research outputs
Top Co-Authors

Avatar

Christine May Cabiling

Edwards Lifesciences Corporation

View shared research outputs
Top Co-Authors

Avatar

Lillian Quintero

Edwards Lifesciences Corporation

View shared research outputs
Top Co-Authors

Avatar

Alain F. Carpentier

Edwards Lifesciences Corporation

View shared research outputs
Top Co-Authors

Avatar

H. Chris Sarner

Edwards Lifesciences Corporation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tan Thanh Dinh

Edwards Lifesciences Corporation

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge